# Lycopene Following Aneurysmal Subarachnoid Haemorrhage

Study · id `cardio:ct-nct00905931` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00905931](<https://clinicaltrials.gov/study/NCT00905931>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT00905931

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 124 participants.

## Technical summary

Registry record NCT00905931. Randomized; quadruple masking; primary purpose prevention. Start 2010-09 (registry gives no type); primary completion 2012-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 124 participants (planned count; ClinicalTrials.gov record NCT00905931, source copy `cardio:ctgov-nct00905931-2010-06-11`, retrieved 2026-10-31)
- Start date: 2010-09 (registry gives no type) (ClinicalTrials.gov record NCT00905931, source copy `cardio:ctgov-nct00905931-2010-06-11`, retrieved 2026-10-31)
- Primary completion: 2012-06 (anticipated) (ClinicalTrials.gov record NCT00905931, source copy `cardio:ctgov-nct00905931-2010-06-11`, retrieved 2026-10-31)
- Completion: 2012-10 (anticipated) (ClinicalTrials.gov record NCT00905931, source copy `cardio:ctgov-nct00905931-2010-06-11`, retrieved 2026-10-31)
- Countries: United Kingdom (ClinicalTrials.gov record NCT00905931, source copy `cardio:ctgov-nct00905931-2010-06-11`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00905931-2010-06-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: Lycopene Following Aneurysmal Subarachnoid Haemorrhage
- Acronym: LASH
- Condition: Subarachnoid Hemorrhage
- Condition: Aneurysm
- Intervention (Drug): Lycopene
- Intervention (Drug): placebo
- Lead sponsor: University of Cambridge
- Lead sponsor class: OTHER
- Collaborator: Cambridge Theranostics Ltd
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry lists this organization as the lead sponsor: University of Cambridge (`cardio:org-university-of-cambridge`)

## Provenance

Content hash: aa21708979a2a6d686a6be1320734b51010e346f8e565e7381b5715fdd8ba73b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
